ZA982335B - Salt of naphthyridine carboxylic acid derivative. - Google Patents

Salt of naphthyridine carboxylic acid derivative.

Info

Publication number: ZA982335B
Authority: ZA; South Africa
Prior art keywords: salt; carboxylic acid; acid derivative; naphthyridine carboxylic; naphthyridine
Prior art date: 1997-03-21

Application number

ZA9802335A

Other languages

English (en)

Inventor

Ae Ri Kim

Jin Hwa Lee

Ki Sook Park

Jong Ryoo Choi

Tae Hee Lee

Jay Hyok Chang

Do Hyun Nam

Hoon Choi

Original Assignee

Lg Chemical Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-03-21

Filing date

1998-03-19

Publication date

1999-11-23

1998-03-19 Application filed by Lg Chemical Ltd filed Critical Lg Chemical Ltd

1999-11-23 Publication of ZA982335B publication Critical patent/ZA982335B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ZA9802335A 1997-03-21 1998-03-19 Salt of naphthyridine carboxylic acid derivative. ZA982335B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
KR19970009840		1997-03-21

Publications (1)

Publication Number	Publication Date
ZA982335B true ZA982335B (en)	1999-11-23

Family

ID=19500439

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9802335A ZA982335B (en)	1997-03-21	1998-03-19	Salt of naphthyridine carboxylic acid derivative.

Country Status (39)

Country	Link
US (9)	US7700617B2 (fr)
EP (2)	EP1179533B1 (fr)
JP (3)	JP3759962B2 (fr)
KR (1)	KR100266499B1 (fr)
CN (1)	CN1131229C (fr)
AP (1)	AP1331A (fr)
AR (1)	AR012125A1 (fr)
AT (2)	ATE257836T1 (fr)
AU (1)	AU726634B2 (fr)
BG (1)	BG63972B1 (fr)
BR (1)	BR9808290A (fr)
CA (1)	CA2283671C (fr)
CZ (2)	CZ288673B6 (fr)
DE (2)	DE69814378T2 (fr)
DK (2)	DK0981527T3 (fr)
DZ (1)	DZ2448A1 (fr)
EA (1)	EA001674B1 (fr)
ES (2)	ES2213669T3 (fr)
HK (1)	HK1026698A1 (fr)
HU (2)	HU225412B1 (fr)
ID (1)	ID22681A (fr)
IL (2)	IL131812A0 (fr)
IN (1)	IN188178B (fr)
IS (2)	IS2093B (fr)
MA (1)	MA24500A1 (fr)
MY (1)	MY137653A (fr)
NO (1)	NO312515B1 (fr)
NZ (1)	NZ337748A (fr)
OA (1)	OA11161A (fr)
PE (1)	PE67999A1 (fr)
PL (1)	PL191815B1 (fr)
PT (2)	PT1179533E (fr)
SA (1)	SA98181055B1 (fr)
SI (2)	SI0981527T1 (fr)
SK (1)	SK284107B6 (fr)
TR (1)	TR199902313T2 (fr)
UA (1)	UA56218C2 (fr)
WO (1)	WO1998042705A1 (fr)
ZA (1)	ZA982335B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9820405D0 (en)	1998-09-18	1998-11-11	Smithkline Beecham Plc	Process
EP1169027A4 (fr) *	1999-03-19	2004-10-20	Abbott Gmbh & Co Kg	Traitement de l'arthrose
US6331550B1 (en)	1999-06-29	2001-12-18	Smithkline Beecham Corporation	Methods of use of quinolone compounds against anaerobic pathogenic bacteria
US6262071B1 (en)	1999-06-29	2001-07-17	Smithkline Beecham Corporation	Methods of use of antimicrobial compounds against pathogenic amycoplasma bacteria
US6803376B1 (en)	1999-06-29	2004-10-12	Smithkline Beecham Corporation	Method of use of quinolone compounds against pneumococcal and haemophilus bacteria
CA2282066C (fr)	1999-06-29	2010-09-07	Smithkline Beecham Corporation	Methodes d'utilisation de composes de quinolone contre des bacteries pathogenes atypiques dans les voies respiratoires superieures
GB9920917D0 (en)	1999-09-03	1999-11-10	Sb Pharmco Inc	Novel process
GB9920919D0 (en)	1999-09-03	1999-11-10	Sb Pharmco Inc	Novel compound
JP2001097891A (ja) *	1999-09-24	2001-04-10	Smithkline Beecham Corp	呼吸器系病原菌に対するフルオロキノロン化合物の使用法
JP2001097864A (ja) *	1999-09-24	2001-04-10	Smithkline Beecham Corp	呼吸管および尿路病原性細菌に対するフルオロキノリン化合物の使用方法
GR1003520B (el) *	1999-09-22	2001-01-22	Smithkline Beecham Plc	Μεθοδος χρησης ενωσεων φλουοροκινολονης εναντια σε νοσοκομειακα αρνητικα κατα gramμ παθογενων βακτηριδιων
AU7709400A (en) *	1999-09-22	2001-04-24	Smithkline Beecham Corporation	Methods of use of fluoroquinolone compounds against bacteria
JP2001097863A (ja) *	1999-09-24	2001-04-10	Smithkline Beecham Corp	嫌気性病原菌に対するフルオロキノロン化合物の使用法
GR1003521B (el) *	1999-09-23	2001-01-22	Smithkline Beecham Plc	Μεθοδοι χρησεως ενωσεων φλουοροκινολονης εναντια κατα gram θετικων παθογονων βακτηριδιων
KR20010091379A (ko) *	2000-03-15	2001-10-23	성재갑	7-(4-아미노메틸-3-옥심)피롤리딘 치환체를 갖는 퀴놀린카르복실산 유도체의 신규 제조방법
DK1412078T3 (da)	2001-08-02	2009-02-02	Lg Life Sciences Ltd	Fremgangsmåde til fremstilling af amino-beskyttede derivater af 4-aminomethylen-pyrrolidin-3-on, Gemifloxacin eller salte deraf
EP1458391B1 (fr) *	2001-11-30	2007-09-05	LG Life Sciences Ltd.	Methode de traitement des infections bacteriennes a l'aide de gemifloxacine ou d'un sel de celle-ci et d'une beta-lactamine
KR100517638B1 (ko) *	2002-04-08	2005-09-28	주식회사 엘지생명과학	게미플록사신 산염의 새로운 제조방법
AR043880A1 (es) *	2003-04-22	2005-08-17	Solvay Pharm Gmbh	Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas
EP2161270A1 (fr)	2005-06-15	2010-03-10	Hetero Drugs Limited	Hydrates de gémifloxacin
MX2008011376A (es) *	2006-03-07	2009-02-06	Wockhardt Ltd	Profarmacos de acido benzoquinolizin-2-carboxilico.
WO2010001408A2 (fr) *	2008-06-06	2010-01-07	Matrix Laboratories Ltd.	Nouvelles formes polymorphes du mésylate de gémifloxacine
WO2010146594A1 (fr) *	2009-06-16	2010-12-23	Hetero Research Foundation	Nouveaux polymorphes de mésylate de gémifloxacine
EP2491921A1 (fr) *	2011-02-25	2012-08-29	Deva Holding Anonim Sirketi	Conservation de la forme anhydre de gemifloxacine
ES2746031T3 (es) *	2012-02-27	2020-03-04	Bristol Myers Squibb Co	Sal de N-(5S,6S,9R)-5-amino-6-(2,3-difluorofenil)-6,7,8,9-tetrahidro-5H-ciclohepta[B]piridin-9-IL-4-(2-oxo-2,3-dihidro-1H-imidazo[4,5-B]piridin-1-il)piperidina-1-carboxilato
CZ2016104A3 (cs) *	2016-02-24	2017-09-06	Zentiva, K.S.	Krystalické modifikace solí methyl (3Z)-3-{[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}fenyl)amino](fenyl)methyliden}-2-oxo-2,3-dihydro-1H-indol-6-karboxylátu a způsoby jejich přípravy

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR223983A1 (es)	1978-08-25	1981-10-15	Dainippon Pharmaceutical Co	Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
ES8304117A1 (es)	1981-06-11	1983-02-16	Warner Lambert Co	"un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".
IN162769B (fr)	1984-11-13	1988-07-09	Kyorin Seiyaku Kk
NZ222047A (en)	1986-10-08	1991-01-29	Bristol Myers Co	Quinoline - or naphthyridine - carboxylic acid anti-bacterial agents
JPH01100165A (ja)	1987-10-13	1989-04-18	Shionogi & Co Ltd	オキシムまたはヒドロキシアミン誘導体系抗菌剤
US4920120A (en)	1988-01-25	1990-04-24	Warner-Lambert Company	Antibacterial agents
US4931446A (en) *	1988-03-23	1990-06-05	Abbott Laboratories	Antimicrobial for in-vitro diagnostic kits
US5286723A (en) *	1988-08-31	1994-02-15	Daiichi Seiyaku Co., Ltd.	Spiro compound
CA1336090C (fr) *	1988-08-31	1995-06-27	Isao Hayakawa	Amines cycliques a substituant spiro de derives de la quinolone
PL166381B1 (pl)	1989-08-16	1995-05-31	Pfizer	Sposób wytwarzania nowych podstawionych kwasów 7-azabicyklochinolonokarboksylowych PL PL PL PL
EP0541086A1 (fr)	1991-11-08	1993-05-12	Kaken Pharmaceutical Co., Ltd.	Fluoro-6-chinolones antibactériennes ayant un groupe oxime sur le substituant en position 7
WO1993025545A1 (fr)	1992-06-09	1993-12-23	Korea Research Institute Of Chemical Technology	Nouveaux derives de quinoleine et procedes pour leur preparation
DK0688772T3 (da) *	1994-06-16	1999-11-01	Lg Chemical Ltd	Quinolincarboxylsyrederivater med 7-(4-aminomethyl-3-oxim)-pyrrolidinsubstituenter og fremgangsmåde til deres fremstilling
US5776944A (en) *	1994-06-16	1998-07-07	Lg Chemical Ltd.	7-(4-aminomethyl-3-methyloxyiminopyrroplidin-1-yl)-1-cyclopropyl-6-flu oro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof
EP0787720B1 (fr)	1994-10-20	2003-07-16	Wakunaga Seiyaku Kabushiki Kaisha	Derive de pyridone-carboxylate, ou sel de celui-ci, et antibacterien le contenant comme principe actif
AU5260096A (en)	1995-01-30	1996-08-21	Wakunaga Seiyaku Kabushiki Kaisha	Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agent containing the same as active ingredient
ES2117426T3 (es)	1995-06-06	1998-08-01	Pfizer	Forma cristalina de la sal anhidra compuesta de los acidos 7-((1a,5a,6a)-6-amino-3-azabiciclo(3.1.0.)hex-3-il)-6-fluoro-1-(2,4-difluorofenil)-1,4-dihidro-4-oxo-1,8-naftiridina-3-carboxilico y metanosulfonico.
US20020032216A1 (en) *	1997-03-21	2002-03-14	Lg Chemical Ltd.	Salt of naphthyridine carboxylic acid derivative
KR100286874B1 (ko) *	1998-03-04	2001-04-16	성재갑	보호된 4-아미노메틸-피롤리딘-3-온의 제조방법
GB9820405D0 (en)	1998-09-18	1998-11-11	Smithkline Beecham Plc	Process

1998
- 1998-03-17 MA MA25001A patent/MA24500A1/fr unknown
- 1998-03-18 DZ DZ980058A patent/DZ2448A1/fr active
- 1998-03-19 ZA ZA9802335A patent/ZA982335B/xx unknown
- 1998-03-20 AT AT01203507T patent/ATE257836T1/de active
- 1998-03-20 EP EP01203507A patent/EP1179533B1/fr not_active Expired - Lifetime
- 1998-03-20 HU HU0000728A patent/HU225412B1/hu unknown
- 1998-03-20 KR KR1019980009717A patent/KR100266499B1/ko active IP Right Grant
- 1998-03-20 DE DE69814378T patent/DE69814378T2/de not_active Expired - Lifetime
- 1998-03-20 IL IL13181298A patent/IL131812A0/xx active IP Right Grant
- 1998-03-20 SI SI9830418T patent/SI0981527T1/xx unknown
- 1998-03-20 PT PT01203507T patent/PT1179533E/pt unknown
- 1998-03-20 WO PCT/KR1998/000051 patent/WO1998042705A1/fr active IP Right Grant
- 1998-03-20 AR ARP980101268A patent/AR012125A1/es active IP Right Grant
- 1998-03-20 ID IDW991044A patent/ID22681A/id unknown
- 1998-03-20 BR BR9808290-6A patent/BR9808290A/pt not_active Application Discontinuation
- 1998-03-20 UA UA99095186A patent/UA56218C2/uk unknown
- 1998-03-20 HU HU0600401A patent/HU227536B1/hu unknown
- 1998-03-20 NZ NZ337748A patent/NZ337748A/xx not_active IP Right Cessation
- 1998-03-20 DE DE69821147T patent/DE69821147T2/de not_active Expired - Lifetime
- 1998-03-20 CA CA002283671A patent/CA2283671C/fr not_active Expired - Lifetime
- 1998-03-20 EP EP98908300A patent/EP0981527B1/fr not_active Expired - Lifetime
- 1998-03-20 DK DK98908300T patent/DK0981527T3/da active
- 1998-03-20 AU AU66366/98A patent/AU726634B2/en not_active Expired
- 1998-03-20 SI SI9830595T patent/SI1179533T1/ unknown
- 1998-03-20 ES ES01203507T patent/ES2213669T3/es not_active Expired - Lifetime
- 1998-03-20 PT PT98908300T patent/PT981527E/pt unknown
- 1998-03-20 PL PL335812A patent/PL191815B1/pl unknown
- 1998-03-20 AT AT98908300T patent/ATE239724T1/de active
- 1998-03-20 JP JP54550098A patent/JP3759962B2/ja not_active Expired - Lifetime
- 1998-03-20 IL IL131812A patent/IL131812A/en not_active IP Right Cessation
- 1998-03-20 CZ CZ19993282A patent/CZ288673B6/cs not_active IP Right Cessation
- 1998-03-20 SK SK1236-99A patent/SK284107B6/sk not_active IP Right Cessation
- 1998-03-20 TR TR1999/02313T patent/TR199902313T2/xx unknown
- 1998-03-20 PE PE1998000202A patent/PE67999A1/es not_active Application Discontinuation
- 1998-03-20 AP APAP/P/1999/001649A patent/AP1331A/en active
- 1998-03-20 CN CN98803576A patent/CN1131229C/zh not_active Expired - Lifetime
- 1998-03-20 DK DK01203507T patent/DK1179533T3/da active
- 1998-03-20 ES ES98908300T patent/ES2198697T3/es not_active Expired - Lifetime
- 1998-03-20 EA EA199900855A patent/EA001674B1/ru not_active IP Right Cessation
- 1998-03-21 MY MYPI98001236A patent/MY137653A/en unknown
- 1998-03-23 IN IN727DE1998 patent/IN188178B/en unknown
- 1998-03-25 SA SA98181055A patent/SA98181055B1/ar unknown
1999
- 1999-09-14 IS IS5181A patent/IS2093B/is unknown
- 1999-09-20 OA OA9900213A patent/OA11161A/fr unknown
- 1999-09-21 BG BG103750A patent/BG63972B1/bg unknown
- 1999-09-21 NO NO19994595A patent/NO312515B1/no not_active IP Right Cessation
2000
- 2000-08-30 HK HK00105435A patent/HK1026698A1/xx not_active IP Right Cessation
- 2000-10-03 CZ CZ20003641A patent/CZ288715B6/cs not_active IP Right Cessation
2003
- 2003-05-07 JP JP2003128650A patent/JP4781614B2/ja not_active Expired - Lifetime
2005
- 2005-07-21 IS IS7952A patent/IS2095B/is unknown
2006
- 2006-12-07 US US11/635,069 patent/US7700617B2/en not_active Expired - Fee Related
2008
- 2008-10-14 JP JP2008265345A patent/JP2009051851A/ja not_active Withdrawn
2009
- 2009-01-09 US US12/318,845 patent/US20090182006A1/en not_active Abandoned
2010
- 2010-06-02 US US12/791,957 patent/US20100240694A1/en not_active Abandoned
2011
- 2011-04-11 US US13/083,685 patent/US20110312987A1/en not_active Abandoned
2012
- 2012-06-26 US US13/533,383 patent/US20130065917A1/en not_active Abandoned
2013
- 2013-10-25 US US14/063,117 patent/US20140187576A1/en not_active Abandoned
2015
- 2015-02-13 US US14/621,689 patent/US20150291585A1/en not_active Abandoned
2016
- 2016-01-15 US US14/996,765 patent/US20160264569A1/en not_active Abandoned
2017
- 2017-01-20 US US15/411,030 patent/US20170253588A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ID22681A (id)	1999-12-09
IS5181A (is)	1999-09-14
EP1179533B1 (fr)	2004-01-14
ATE239724T1 (de)	2003-05-15
JP2000510484A (ja)	2000-08-15
IN188178B (fr)	2002-08-31
BG103750A (en)	2000-06-30
CZ328299A3 (cs)	2000-02-16
HUP0600401A3 (en)	2010-05-28
US20080039488A1 (en)	2008-02-14
US20110312987A1 (en)	2011-12-22
DE69814378T2 (de)	2004-02-26
JP2009051851A (ja)	2009-03-12
DK1179533T3 (da)	2004-05-03
CA2283671A1 (fr)	1998-10-01
ES2198697T3 (es)	2004-02-01
PT981527E (pt)	2003-09-30
HUP0000728A3 (en)	2002-12-28
HU227536B1 (en)	2011-08-29
SI1179533T1 (en)	2004-04-30
NO312515B1 (no)	2002-05-21
TR199902313T2 (xx)	1999-12-21
HUP0000728A2 (hu)	2000-09-28
JP4781614B2 (ja)	2011-09-28
NO994595D0 (no)	1999-09-21
AP1331A (en)	2004-11-26
KR100266499B1 (ko)	2000-12-01
HK1026698A1 (en)	2000-12-22
ES2213669T3 (es)	2004-09-01
PL191815B1 (pl)	2006-07-31
SK123699A3 (en)	2000-08-14
EP0981527B1 (fr)	2003-05-07
MY137653A (en)	2009-02-27
HU0600401D0 (en)	2006-07-28
NO994595L (no)	1999-09-21
US20090182006A1 (en)	2009-07-16
DZ2448A1 (fr)	2003-01-11
JP2004002413A (ja)	2004-01-08
PL335812A1 (en)	2000-05-22
EP1179533A2 (fr)	2002-02-13
SK284107B6 (sk)	2004-09-08
IL131812A0 (en)	2001-03-19
WO1998042705A1 (fr)	1998-10-01
AU726634B2 (en)	2000-11-16
HU225412B1 (en)	2006-11-28
CZ288673B6 (cs)	2001-08-15
US20160264569A1 (en)	2016-09-15
AP9901649A0 (en)	1999-09-30
BG63972B1 (bg)	2003-08-29
PE67999A1 (es)	1999-09-30
ATE257836T1 (de)	2004-01-15
DK0981527T3 (da)	2003-09-01
EA199900855A1 (ru)	2000-04-24
US20100240694A1 (en)	2010-09-23
CN1131229C (zh)	2003-12-17
BR9808290A (pt)	2000-05-16
US20170253588A1 (en)	2017-09-07
US20150291585A1 (en)	2015-10-15
DE69821147D1 (de)	2004-02-19
EP0981527A1 (fr)	2000-03-01
US7700617B2 (en)	2010-04-20
CN1251101A (zh)	2000-04-19
CZ288715B6 (cs)	2001-08-15
NZ337748A (en)	2001-03-30
AR012125A1 (es)	2000-09-27
IS7952A (is)	2005-07-21
SI0981527T1 (en)	2003-10-31
DE69821147T2 (de)	2004-11-11
DE69814378D1 (de)	2003-06-12
KR19980080504A (ko)	1998-11-25
IS2093B (is)	2006-04-12
UA56218C2 (uk)	2003-05-15
PT1179533E (pt)	2004-05-31
EA001674B1 (ru)	2001-06-25
CA2283671C (fr)	2003-09-16
MA24500A1 (fr)	1998-10-01
US20140187576A1 (en)	2014-07-03
IS2095B (is)	2006-04-12
AU6636698A (en)	1998-10-20
IL131812A (en)	2006-04-10
EP1179533A3 (fr)	2002-03-20
SA98181055B1 (ar)	2006-10-11
OA11161A (en)	2003-04-25
JP3759962B2 (ja)	2006-03-29
US20130065917A1 (en)	2013-03-14

Publication	Publication Date	Title
ZA982335B (en)	1999-11-23	Salt of naphthyridine carboxylic acid derivative.
HK1043124A1 (en)	2002-09-06	Salt of naphthyridine carboxylic acid derivative.
PL334997A1 (en)	2000-03-27	Derivatives or arylosulphonyl-hydroxamic acid
HK1039939A1 (zh)	2002-05-17	α-取代羧酸衍生物
HU9801044D0 (en)	1998-07-28	Sulfonyl-amino-carboxylic acid derivatives
HUP0003881A3 (en)	2001-04-28	Amidocarboxylic acid derivatives
HUP9902645A3 (en)	1999-12-28	Fused-ring carboxylic acid derivatives
AU2006699A (en)	1999-07-19	Phosphinic alkanoic acid derivatives
HUP9901966A3 (en)	2002-01-28	Quinolonecarboxylic acid derivatives or salts thereof
ZA9810298B (en)	1999-05-18	Isothiazole carboxylic acid derivatives
AU7940598A (en)	1999-01-19	Quinolone carboxylic acid derivatives
IL129135A0 (en)	2000-02-17	3-Alkoxyisoxazol-4- YL-substituted 2-amino carboxylic acid compounds
AU697025B2 (en)	1998-09-24	Quinoline carboxylic acid
HUT75640A (en)	1997-05-28	Novel quinolone carboxylic acid derivatives
PL335601A1 (en)	2000-05-08	Derivatives of 2-substituted benzoylcycloalkyl carboxylic acid
IL123213A0 (en)	1998-09-24	Carboxylic acid derivatives
GB2318789B (en)	2001-03-21	Carboxylic acid derivatives,method of manufacturing the same and therapeutic agents containing these compounds
HRP940833A2 (en)	1996-12-31	1-(2-fluorocyclopropyl)-quinoline- and naphthyridone carboxylic acid derivatives
GB9907082D0 (en)	1999-05-19	The preparation of carboxylic acid derivatives
AU3076295A (en)	1996-02-16	Heterocyclyl-1-phenyl substituted quinolone carboxylic acids as antiviral agents
AU6516998A (en)	1998-10-20	Lipid a1-position carboxylic acid derivatives
ZA976429B (en)	1998-02-18	Benzoylpropionic acid ester derivatives.
SI0934286T1 (en)	2003-06-30	3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
GB9306448D0 (en)	1993-05-19	Carboxylic acid derivatives
GB9325620D0 (en)	1994-02-16	Carboxylic acid derivatives